GlassScriptPhysician profile
Jacob Daniel Miller
NPI 1619105871
$15,227.93
in general payments reported to CMS, 2019-2025
23 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,665 · 2020: $1,761 · 2021: $767 · 2022: $4,201 · 2023: $375 · 2024: $148 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,549.54 | 2019-2025 | Acufex Meniscal Root Repair, Coblation, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Arthrex, INC. | $2,882.33 | 2021-2022 | |
| Rock Medical Orthopedics, INC. | $1,661.62 | 2021-2022 | |
| Si-Bone, INC. | $1,466.74 | 2020-2021 | |
| Cdc Medical LLC | $1,447.00 | 2019 | |
| Stryker Corporation | $178.66 | 2023 | Mako, Pro-Dense |
| Vericel Corporation | $177.97 | 2019-2024 | Maci |
| Integra Lifesciences Corporation | $165.15 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Angiodynamics, INC. | $132.81 | 2025 | Alphavac |
| Microport Orthopedics INC | $125.14 | 2020 | |
| Innovation Technologies INC | $96.33 | 2022 | |
| Pacira Therapeutics, INC. | $86.56 | 2019-2021 | |
| Depuy Synthes Sales INC. | $64.12 | 2025 | Truespan Orthocord, Healix Knotless Peek |
| Kerecis Limited | $30.06 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| My01 INC. | $29.27 | 2024 | My01 Continuous Compartmental Pressure Monitor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $24.77 | 2023 | Zynrelef |
| Nexus Medical Technologies LLC | $21.97 | 2025 | |
| Sanara Medtech INC. | $16.75 | 2024 | Celleraterx |
| Convatec INC. | $15.47 | 2021 | |
| Bioventus LLC | $14.67 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.64 | 2025 | |
| Pfizer INC. | $13.48 | 2021 | |
| Orthofix Medical, INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.